Latest news
Highlights From EHA 2026: The Latest Findings in Myeloproliferative Neoplasms - cancertherapyadvisor.comcancertherapyadvisor.com · Fri, 07 Aug 2026 06:46:51 GMTMyelofibrosis: selinexor added to ruxolitinib increases spleen response but not symptom benefit - Vera HealthVera Health · Sat, 01 Aug 2026 04:14:54 GMTKaryopharm plans selinexor-ruxolitinib combination filing for myelofibrosis accelerated approval - AllSciAllSci · Fri, 31 Jul 2026 12:29:21 GMTKaryopharm Plans to Submit sNDA for Selinexor Plus Ruxolitinib in Myelofibrosis Under Accelerated Approval Pathway - PR NewswirePR Newswire · Thu, 30 Jul 2026 07:00:00 GMT